Results 151 to 160 of about 23,148 (170)

Relationship between urinary sodium excretion and pioglitazone‐induced edema

Journal of Diabetes Investigation, 2010
Akinobu Nakamura, Takeshi Osonoi, Yasuo Terauchi   +2 more
exaly  

Activation of Human Peroxisome Proliferator-Activated Receptor (PPAR) Subtypes by Pioglitazone

Biochemical and Biophysical Research Communications, 2000
Hiroyuki Odaka, Yu Momose, Y Sugiyama
exaly  

Effects of Pioglitazone in Patients With Type 2 Diabetes With or Without Previous Stroke

Stroke, 2007
D John Betteridge, Guntram Schernthaner, Valdis Pirags   +2 more
exaly  

Efficacy and tolerability of initial combination therapy with vildagliptin and pioglitazone compared with component monotherapy in patients with type 2 diabetes

Diabetes, Obesity and Metabolism, 2007
S Dejager
exaly  

Increased risk of bladder cancer with pioglitazone therapy in patients with diabetes: A meta-analysis

Diabetes Research and Clinical Practice, 2012
Zhaowei Zhu, Zhoujun Shen, Yingli Lu
exaly  

Empagliflozin improves glycaemic and weight control as add‐on therapy to pioglitazone or pioglitazone plus metformin in patients with type 2 diabetes: a 24‐week, randomized, placebo‐controlled trial

Diabetes, Obesity and Metabolism, 2014
Christopher S Kovacs, H J Woerle, U C Broedl   +2 more
exaly  

Pioglitazone for Secondary Stroke Prevention

Stroke, 2017
Meng Lee, Jeffrey L Saver, Hung-Wei Liao   +2 more
exaly  

Pioglitazone and bladder cancer risk: a systematic review and meta‐analysis

Cancer Medicine, 2018
Huilin Tang, Weilong Shi, Shuangshuang Fu   +2 more
exaly  

Pioglitazone

2018
openaire   +1 more source

Evidence for the Importance of Adiponectin in the Cardioprotective Effects of Pioglitazone

Hypertension, 2010
Rei Shibata, Kazumasa Unno, Masayuki Shimano   +2 more
exaly